Tokumitsu H, Wayman G A, Muramatsu M, Soderling T R
Vollum Institute, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97201, USA.
Biochemistry. 1997 Oct 21;36(42):12823-7. doi: 10.1021/bi971348i.
We recently cloned a calmodulin-dependent protein kinase kinase (CaM-KK) which phosphorylates and activates CaM-KI and CaM-KIV [Tokumitsu, H., Enslen, H., and Soderling, T. R. (1995) J. Biol. Chem. 270, 19320-19324]. In the present study, we have identified its regulatory CaM-binding and autoinhibitory domains (CBD and AID, respectively) using a series of COOH-terminal truncations and site-directed mutants expressed in COS-7 cells. Truncation mutant CaM-KK1-463 activated CaM-KIV and bound CaM similar to wild-type enzyme (CaM-KK1-505); CaM-KK1-448 did not bind CaM and was largely inactive; and CaM-KK1-434 also did not bind CaM but activated a CaM-independent mutant of CaM-KIV in the absence of Ca2+/CaM. Substitution of triple negative charges (Asp) at positions 455RKR, 448ILV, or 443SWT blocked CaM binding and suppressed by 70-90% CaM-KK activities. Mutants 438VKL and 435KNS to DDD exhibited partial Ca2+/CaM-independent activities. These results identify overlapping AID and CBD between residues 430 and 460 in CaM-KK, similar to other CaM-Ks. Consistent with this assignment, the synthetic peptide corresponding to residues 438-463 bound CaM in a Ca2+-dependent manner with a Kd in the low nanomolar range. Furthermore, phosphorylation by cAMP-kinase of Ser458 at the COOH-terminus of the CBD in CaM-KK, which suppresses subsequent CaM binding [Wayman, G., Tokumitsu, H., and Soderling, T. R. (1997) J. Biol. Chem. 272, 16073-16076], was blocked by prior binding of Ca2+/CaM to CaM-KK.
我们最近克隆了一种钙调蛋白依赖性蛋白激酶激酶(CaM-KK),它可磷酸化并激活CaM-KI和CaM-KIV [德光博史、恩斯伦、索德林,《生物化学杂志》,第270卷,第19320 - 19324页(1995年)]。在本研究中,我们通过在COS-7细胞中表达的一系列COOH末端截短体和定点突变体,鉴定了其调节性钙调蛋白结合域和自身抑制域(分别为CBD和AID)。截短突变体CaM-KK1 - 463激活CaM-KIV并结合钙调蛋白,与野生型酶(CaM-KK1 - 505)相似;CaM-KK1 - 448不结合钙调蛋白且基本无活性;CaM-KK1 - 434也不结合钙调蛋白,但在无Ca2+/钙调蛋白的情况下激活了CaM-KIV的一个不依赖钙调蛋白的突变体。在455RKR、448ILV或443SWT位点替换三个负电荷(天冬氨酸)可阻断钙调蛋白结合,并使CaM-KK活性降低70 - 90%。438VKL和435KNS突变为DDD的突变体表现出部分不依赖Ca2+/钙调蛋白的活性。这些结果表明,与其他CaM-Ks类似,CaM-KK中430至460位残基之间存在重叠的AID和CBD。与此一致的是,对应于438 - 463位残基的合成肽以Ca2+依赖的方式结合钙调蛋白,解离常数在低纳摩尔范围内。此外,CaM-KK中CBD的COOH末端的Ser458被cAMP激酶磷酸化后会抑制随后的钙调蛋白结合[韦曼、德光博史、索德林,《生物化学杂志》,第272卷,第16073 - 16076页(1997年)],而Ca2+/钙调蛋白与CaM-KK的预先结合可阻断这种磷酸化。